跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AGT-1
首页
药物
AGT-1
AGT-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PNA probes, probe sets, methods and kits pertaining to the detection of Candida
US 8026051 B2
申请人: BOSTON PROBES INC
优先权: 2002
US
7 件公开
Recombinant Candida rugosa lipases
US 7052879 B2
申请人: ACADEMIA SINICA
优先权: 2001
US
6 件公开
SIRNA, SIRNA CONJUGATE, PHARMACEUTICAL COMPOSITION AND USE THEREOF
US 20260167968 A1
申请人: CHENGDU GOWELL BIOPHARMACEUTICAL CO LTD
优先权: 2023
CN
US
WO
3 件公开
EP 4772633 A1
申请人: CHENGDU GOWELL BIOPHARMACEUTICAL CO LTD
优先权: 2023
EP
Mutants of O6-alkylguanine-DNA alkyltransferase
US 7888090 B2
申请人: ECOLE POLYTECH
优先权: 2004
US
3 件公开
DOUBLE-STRANDED RNA FOR REGULATING ANGIOTENSINOGEN GENE EXPRESSION, AND CONJUGATE, PHARMACEUTICAL COMPOSITION AND USE THEREOF
WO 2024234831 A1
申请人: SUZHOU SIRAN BIOTECHNOLOGY CO LTD
优先权: 2023
CN
WO
2 件公开
DOUBLE-STRANDED OLIGONUCLEOTIDE AND USE THEREOF IN INHIBITING EXPRESSION OF ANGIOTENSINOGEN
WO 2025044868 A9
申请人: RIGERNA THERAPEUTICS SUZHOU CO LTD
优先权: 2023
CN
WO
2 件公开
GRNA TARGETING AGT GENE AND USE THEREOF
WO 2025157184 A1
申请人: YOLTECH THERAPEUTICS CO LTD
优先权: 2024
CN
WO
2 件公开
O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs
US 7825096 B2
申请人: US HEALTH
优先权: 2007
US
2 件公开
Substrates for O6-alkylguanina-DNA alkyltransferase
US 7799524 B2
申请人: ECOLE POLYTECHNIQUE FERDEALE D
优先权: 2002
US
Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase
US 2007243568 A1
申请人: JACCARD HUGHES
优先权: 2004
US
第 1 / 3 页
上一页
下一页
药物
反馈